Replimune (REPL) Cash from Investing Activities Growth (1y) (2018 - 2025)
Replimune (REPL) Cash from Investing Activities Growth (1y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Replimune |
780.01 Mn |
510.88 Mn |
- |
262.18% |
| Date | Value |
|---|
| Dec 31, 2025 |
262.18% |
| Sep 30, 2025 |
18,277.51% |
| Jun 30, 2025 |
118.53% |
| Mar 31, 2025 |
-133.19% |
| Dec 31, 2024 |
-185.85% |
| Sep 30, 2024 |
-96.39% |
| Jun 30, 2024 |
304.37% |
| Mar 31, 2024 |
201.97% |
| Dec 31, 2023 |
143.13% |
| Sep 30, 2023 |
35,130.56% |
| Jun 30, 2023 |
38.49% |
| Mar 31, 2023 |
-425.94% |
| Dec 31, 2022 |
-832.20% |
| Sep 30, 2022 |
100.33% |
| Jun 30, 2022 |
-80.31% |
| Mar 31, 2022 |
96.57% |
| Dec 31, 2021 |
-142.71% |
| Sep 30, 2021 |
75.33% |
| Jun 30, 2021 |
154.94% |
| Mar 31, 2021 |
-1,710.42% |
